Centerline Biomedical Inc.’s 3D navigation system for interventional vascular procedures is designed to provide physicians with greater visualization than fluoroscopy,and to reduce caregivers and patients exposure to harmful radiation.

Laurimed LLC has developed PolypVac, a suction-powered microdebrider for treating nasal polyposis, an inflammatory response to chronic inflammation. It is designed to be used in an ENT’s office in a 15-minute procedure performed under local anesthesia.

Top of the agenda for the medtech industry globally is when the “new normal” will return. In the UK, the expectations are that post-COVID-19 health care activity will increase gradually, but it is possible that the National Health Service will not reach its pre-coronavirus capacities until late in 2021, “if at all.”